{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:52:26Z","timestamp":1768812746400,"version":"3.49.0"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T00:00:00Z","timestamp":1543881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G1100693"],"award-info":[{"award-number":["G1100693"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_12023\/23"],"award-info":[{"award-number":["MC_UU_12023\/23"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_12023\/26"],"award-info":[{"award-number":["MC_UU_12023\/26"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["101113\/Z\/13\/Z"],"award-info":[{"award-number":["101113\/Z\/13\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203077\/Z\/16\/Z"],"award-info":[{"award-number":["203077\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1002706","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T18:23:47Z","timestamp":1543947827000},"page":"e1002706","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9286-7052","authenticated-orcid":true,"given":"Cissy","family":"Kityo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2082-0861","authenticated-orcid":true,"given":"Alexander J.","family":"Szubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Siika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Heyderman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutsa","family":"Bwakura-Dangarembizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Lugemwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shalton","family":"Mwaringa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Immaculate","family":"Nkanya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila","family":"Kabahenda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Wachira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Godfrey","family":"Musoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chatu","family":"Rajapakse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Etyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Abach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moira J.","family":"Spyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5064-024X","authenticated-orcid":true,"given":"Priscilla","family":"Wavamunno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3572-3810","authenticated-orcid":true,"given":"Linda","family":"Nyondo-Mipando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ennie","family":"Chidziva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kusum","family":"Nathoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3925-9258","authenticated-orcid":true,"given":"Nigel","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Hakim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9738-5490","authenticated-orcid":true,"given":"Diana M.","family":"Gibb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0412-8509","authenticated-orcid":true,"given":"A. Sarah","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah L.","family":"Pett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the REALITY trial team","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,12,4]]},"reference":[{"key":"ref1","unstructured":"World Health Organisation. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach (second edition) (<ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/hiv\/pub\/arv\/arv-2016\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/hiv\/pub\/arv\/arv-2016\/en\/<\/ext-link>). Geneva: 2016."},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1097\/QAI.0b013e3182a39979","article-title":"Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries","volume":"65","author":"ART IeDea","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"ref3","doi-asserted-by":"crossref","first-page":"e1001718","DOI":"10.1371\/journal.pmed.1001718","article-title":"Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies","volume":"11","author":"A Boulle","year":"2014","journal-title":"PLoS Med"},{"issue":"14","key":"ref4","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1097\/QAD.0b013e32833d45c5","article-title":"Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002\u20132007","volume":"24","author":"M Cornell","year":"2010","journal-title":"AIDS"},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/cid\/cis797","article-title":"Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe","volume":"55","author":"AS Walker","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"12","key":"ref6","doi-asserted-by":"crossref","first-page":"e28691","DOI":"10.1371\/journal.pone.0028691","article-title":"Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis","volume":"6","author":"A Gupta","year":"2011","journal-title":"PLoS ONE"},{"issue":"Suppl 4","key":"ref7","doi-asserted-by":"crossref","first-page":"s2","DOI":"10.1111\/hiv.12426","article-title":"British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015","volume":"17","author":"D Churchill","year":"2016","journal-title":"HIV Med"},{"key":"ref8","unstructured":"Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Available at <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.aidsinfo.nih.gov\/ContentFiles\/AdultandAdolescentGL.pdf\" xlink:type=\"simple\">http:\/\/www.aidsinfo.nih.gov\/ContentFiles\/AdultandAdolescentGL.pdf<\/ext-link>. Accessed 11 November 2018."},{"issue":"13","key":"ref9","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1097\/QAD.0b013e3283546595","article-title":"Gastrointestinal-associated lymphoid tissue immune reconstitution in a randomized clinical trial of raltegravir versus non-nucleoside reverse transcriptase inhibitor-based regimens","volume":"26","author":"DM Asmuth","year":"2012","journal-title":"AIDS"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1097\/QAD.0b013e32835f2b49","article-title":"Differential penetration of raltegravir throughout gastrointestinal tissue: implications for eradication and cure","volume":"27","author":"KB Patterson","year":"2013","journal-title":"AIDS"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nm.2111","article-title":"HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects","volume":"16","author":"MJ Buzon","year":"2010","journal-title":"Nat Med"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/infdis\/jit453","article-title":"Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial","volume":"208","author":"H Hatano","year":"2013","journal-title":"J Infect Dis"},{"issue":"15","key":"ref13","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1097\/QAD.0b013e3283584521","article-title":"The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients","volume":"26","author":"A Vallejo","year":"2012","journal-title":"AIDS"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/hiv.12128","article-title":"Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial","volume":"15","author":"JE Lake","year":"2014","journal-title":"HIV Med"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/cid\/civ327","article-title":"Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s","volume":"61","author":"T Kelesidis","year":"2015","journal-title":"Clin Infect Dis"},{"key":"ref16","unstructured":"Merck Sharp &amp; Dohme. Raltegravir Summary of Product Characteristics (<ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000860\/WC500037405.pdf\" xlink:type=\"simple\">http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000860\/WC500037405.pdf<\/ext-link>, accessed 12 October 2018) 2015."},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1615822","article-title":"Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa","volume":"377","author":"J Hakim","year":"2017","journal-title":"N Engl J Med"},{"key":"ref18","article-title":"Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial","author":"J Mallewa","year":"2018","journal-title":"Lancet HIV"},{"key":"ref19","unstructured":"World Health Organisation. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach (<ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/hiv\/pub\/guidelines\/arv2013\/download\/en\/index.html\" xlink:type=\"simple\">http:\/\/www.who.int\/hiv\/pub\/guidelines\/arv2013\/download\/en\/index.html<\/ext-link>). Geneva: 2013."},{"key":"ref20","unstructured":"Division of AIDS of the US National Institutes of Health. Table for Grading the Severity of Adult and Pediatric Adverse Events v1.0 (<ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/rsc.tech-res.com\/docs\/default-source\/safety\/table_for_grading_severity_of_adult_pediatric_adverse_events.pdf?sfvrsn=6\" xlink:type=\"simple\">https:\/\/rsc.tech-res.com\/docs\/default-source\/safety\/table_for_grading_severity_of_adult_pediatric_adverse_events.pdf?sfvrsn=6<\/ext-link>, accessed 12 October 2018). 2004."},{"key":"ref21","unstructured":"National Institutes of Health Division of Microbiology and Infectious Diseases (DMID). Toxicity tables (<ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.niaid.nih.gov\/sites\/default\/files\/dmidpedtox.pdf\" xlink:type=\"simple\">https:\/\/www.niaid.nih.gov\/sites\/default\/files\/dmidpedtox.pdf<\/ext-link>, accessed 10 March 2017). 2007."},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/01.aids.0000131375.21070.06","article-title":"Immune restoration disease after antiretroviral therapy","volume":"18","author":"MA French","year":"2004","journal-title":"AIDS"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1473-3099(08)70184-1","article-title":"Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings","volume":"8","author":"G Meintjes","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"9868","key":"ref24","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(12)61853-4","article-title":"Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study","volume":"381","author":"F Raffi","year":"2013","journal-title":"Lancet"},{"issue":"18","key":"ref25","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1097\/01.aids.0000194802.89540.e1","article-title":"Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design","volume":"19","author":"SD Lawn","year":"2005","journal-title":"AIDS"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/imr.12064","article-title":"Immune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs","volume":"254","author":"EM Wilson","year":"2013","journal-title":"Immunol Rev"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/hiv.12567","article-title":"Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion","volume":"19","author":"OT Stirrup","year":"2018","journal-title":"HIV Med"},{"issue":"8","key":"ref28","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/cid\/cir510","article-title":"Long-term treatment with raltegravir or efavirenz combined with tenofovir\/emtricitabine for treatment-naive human immunodeficiency virus-1-infected patients: 156-week results from STARTMRK","volume":"53","author":"JK Rockstroh","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/jac\/dkw375","article-title":"Different impact of raltegravir versus efavirenz on CD4\/CD8 ratio recovery in HIV-infected patients","volume":"72","author":"S Serrano-Villar","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"ref30","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1371\/journal.pmed.0050203","article-title":"Inflammatory and coagulation biomarkers and mortality in patients with HIV infection","volume":"5","author":"LH Kuller","year":"2008","journal-title":"PLoS Med"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/infdis\/jiw148","article-title":"Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy","volume":"214","author":"AJ Prendergast","year":"2016","journal-title":"J Infect Dis"},{"key":"ref32","unstructured":"Wijting IEA, Rokx C, Wit FWNM, Postma AM, Hoepelman AIM, van der Ende ME, et al. Integrase Inhibitors are an Independent Risk Factor for IRIS: an ATHENA-Cohort Study. Conference on Retroviruses and Opportunistic Infections; Seattle, WA. 13\u201316 February, 2017."},{"key":"ref33","unstructured":"Dutertre M, Cuzin L, Pugliese P, Joly V, Valantin MA, Cotte L, et al. Initiation of ART based on Integrase Inhibitors increases the risk of IRIS. Conference on Retroviruses and Opportunistic Infections; Seattle, WA. 13\u201316 February, 2017."},{"issue":"11","key":"ref34","doi-asserted-by":"crossref","first-page":"e1002407","DOI":"10.1371\/journal.pmed.1002407","article-title":"Contemporary disengagement from antiretroviral therapy in Khayelitsha, South Africa: A cohort study","volume":"14","author":"SR Kaplan","year":"2017","journal-title":"PLoS Med"},{"issue":"suppl_2","key":"ref35","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1093\/cid\/cix1141","article-title":"Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial","volume":"66","author":"FA Post","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"385 e1","DOI":"10.1016\/j.ajog.2015.12.052","article-title":"Integrase inhibitors in late pregnancy and rapid HIV viral load reduction","volume":"214","author":"L Rahangdale","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"suppl_2","key":"ref37","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1093\/cid\/ciy045","article-title":"Persistent High Burden of Advanced HIV Disease Among Patients Seeking Care in South Africa&apos;s National HIV Program: Data From a Nationwide Laboratory Cohort","volume":"66","author":"S Carmona","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"47","key":"ref38","article-title":"Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013","volume":"20","author":"A Mocroft","year":"2015","journal-title":"Euro Surveill"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1002706","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T15:49:03Z","timestamp":1662565743000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1002706"}},"subtitle":[],"editor":[{"given":"Sydney","family":"Rosen","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,12,4]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1002706","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,4]]}}}